These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 17540194

  • 41. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
    Ruiz-Salas A, García-Pinilla JM, Cabrera-Bueno F, Fernández-Pastor J, Peña-Hernández J, Medina-Palomo C, Barrera-Cordero A, De Teresa E, Alzueta J.
    Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Noninvasive imaging markers associated with sudden cardiac death.
    van der Bijl P, Delgado V, Bax JJ.
    Trends Cardiovasc Med; 2016 May; 26(4):348-60. PubMed ID: 26632012
    [Abstract] [Full Text] [Related]

  • 45. Application of microvolt T-wave alternans testing in scheduling implantable cardioverter-defibrillator placement for the primary prevention of sudden cardiac death in patients with left ventricular dysfunction.
    Daniłowicz-Szymanowicz L, Suchecka J, Zagożdżon P, Szwoch M, Kempa M, Raczak G.
    Kardiol Pol; 2015 May; 73(6):429-36. PubMed ID: 25371309
    [Abstract] [Full Text] [Related]

  • 46. Noninvasive risk stratification for sudden death: signal-averaged electrocardiography, nonsustained ventricular tachycardia, heart rate variability, baroreflex sensitivity, and QRS duration.
    Stein KM.
    Prog Cardiovasc Dis; 2008 May; 51(2):106-17. PubMed ID: 18774010
    [No Abstract] [Full Text] [Related]

  • 47. Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease.
    Atwater BD, Thompson VP, Vest RN, Shaw LK, Mazzei WR, Al-Khatib SM, Hranitzky PM, Bahnson TD, Velazquez EJ, Califf RM, Lee KL, Roe MT.
    Am J Cardiol; 2009 Dec 15; 104(12):1624-30. PubMed ID: 19962465
    [Abstract] [Full Text] [Related]

  • 48. Programmed ventricular stimulation predicts arrhythmic events and survival in hypertrophic cardiomyopathy.
    Gatzoulis KA, Georgopoulos S, Antoniou CK, Anastasakis A, Dilaveris P, Arsenos P, Sideris S, Tsiachris D, Archontakis S, Sotiropoulos E, Theopistou A, Skiadas I, Kallikazaros I, Stefanadis C, Tousoulis D.
    Int J Cardiol; 2018 Mar 01; 254():175-181. PubMed ID: 29407088
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Sudden death and ventricular arrhythmias risk stratification after myocardial infarction].
    Crişu D.
    Rev Med Chir Soc Med Nat Iasi; 2010 Mar 01; 114(1):13-9. PubMed ID: 20509270
    [Abstract] [Full Text] [Related]

  • 52. Electrocardiographic predictors of mortality and sudden cardiac death in patients with end stage renal disease on hemodialysis.
    Waks JW, Tereshchenko LG, Parekh RS.
    J Electrocardiol; 2016 Mar 01; 49(6):848-854. PubMed ID: 27554424
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Risk Markers and Appropriate Implantable Defibrillator Therapy in Hypertrophic Cardiomyopathy.
    Magnusson P, Gadler F, Liv P, Mörner S.
    Pacing Clin Electrophysiol; 2016 Mar 01; 39(3):291-301. PubMed ID: 26681505
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J, Pudło J, Lelakowska-Pieła M, Rydlewska A, Piekarz J, Domaracki D.
    Pol Merkur Lekarski; 2016 Apr 01; 40(238):216-22. PubMed ID: 27137820
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.